Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer's disease and uses thereof

Transgenic mice over-expressing amyloid-beta alcohol dehydrogenase (ABAD) in brain as model of alzheimer's disease and uses thereof

US Patent 6891081 · Granted May 10, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating and preventing multiple sclerosis2016
Compositions for inhibiting ABAD/ABeta protein interaction2013
Compositions for inhibiting ABAD/ABeta protein interaction2013
Method for inhibiting new tissue growth in blood vessels in a patient subjected 2012
Methods for treating ischemic disorders using carbon monoxide2012
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE2012
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE2012
RAGE G82S-related methods and compositions for treating inflammatory disorders2011
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE2011
Transgenic mice over-expressing receptor for advanced glycation endproduct (RAGE2011
Method for inhibiting new tissue growth in blood vessels in a patient subjected 2010
Method for treating symptoms of diabetes2010